Free tool
FAERS Monitor: Felbatol
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020189 or its brand name (Felbatol, Felbamate). Reports on generic versions are filed under their own applications.
Reports
1,779
Serious
1,266
71% of reports
Hospitalization
550
Death reported
89
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- seizure364
- drug ineffective263
- off label use134
- convulsion124
- somnolence114
- condition aggravated92
- fatigue87
- drug interaction73
- vomiting72
- toxicity to various agents71
- generalised tonic-clonic seizure68
- diarrhoea61
- fall61
- weight decreased57
- pneumonia52
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 10 |
| 2005 | 7 |
| 2006 | 23 |
| 2007 | 18 |
| 2008 | 11 |
| 2009 | 15 |
| 2010 | 30 |
| 2011 | 38 |
| 2012 | 73 |
| 2013 | 77 |
| 2014 | 98 |
| 2015 | 128 |
| 2016 | 113 |
| 2017 | 91 |
| 2018 | 104 |
| 2019 | 128 |
| 2020 | 155 |
| 2021 | 163 |
| 2022 | 119 |
| 2023 | 83 |
| 2024 | 111 |
| 2025 | 128 |
| 2026 | 56 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,380 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| generalised tonic-clonic seizureSignal | 68 | 48.8 | 38.6 | 3,124 |
| seizureSignal | 364 | 37.4 | 34.1 | 12,879 |
| convulsionSignal | 124 | 25.7 | 21.7 | 2,919 |
| somnolenceSignal | 114 | 6.7 | 5.6 | 552 |
| drug interactionSignal | 73 | 5.4 | 4.3 | 262 |
| toxicity to various agentsSignal | 71 | 5.0 | 4.0 | 224 |
| condition aggravatedSignal | 92 | 3.6 | 2.9 | 171 |
| weight decreasedSignal | 57 | 2.4 | 1.9 | 46 |
| drug ineffectiveSignal | 263 | 2.4 | 2.1 | 218 |
| fallSignal | 61 | 2.2 | 1.7 | 38 |
| pneumonia | 52 | 1.9 | 1.5 | 22 |
| vomiting | 72 | 1.8 | 1.4 | 26 |
| off label use | 134 | 1.8 | 1.5 | 50 |
| fatigue | 87 | 1.3 | 1.1 | 7 |
| diarrhoea | 61 | 1.1 | 0.9 | 1 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.